BioLineRx (BLRX) Current Assets (2010 - 2026)
BioLineRx (BLRX) reported Current Assets of $16.35 million for the quarter ended Jun 30, 2026, down 48.7% from $31.86 million a year earlier and down 24.2% from the prior quarter.
Powered by 
Analysis
BioLineRx (BLRX) Current Assets (2010 - 2026) Analysis & Trends
As of Dec 31, 2025, BioLineRx posted Current Assets of $23.68 million, down 12.6% from the prior year.
- Current Assets has declined for four consecutive years, though with a five-year compound annual growth rate of 0.7% (years ended Dec 2020 to Dec 2025).
- By year, Current Assets came in at $27.1 million in the year ended Dec 31, 2024 (-42.6%), $47.18 million in the year ended Dec 31, 2023 (-9.3%), $52 million in the year ended Dec 31, 2022 (-9.4%) and $57.4 million in the year ended Dec 31, 2021 (+150.9%).
- The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly Current Assets in data going back to the quarter ended Sep 30, 2011.
- Year over year, Current Assets has now declined in each of the last seven quarters, with an average decline of 21.9% over the last eight quarters.
- The high point for year-over-year Current Assets in five years was the quarter ended Sep 30, 2021 (growth of 193.4%); the low point was the quarter ended Sep 30, 2023 (a decline of 50.3%).
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $21.58 million (quarter ended Mar 31, 2026), $23.68 million (quarter ended Dec 31, 2025) and $28.52 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 41.36 Bn |
| 10 | BioLineRx | 9.10 Mn | -67.42 Mn | 235,000.00 | 16.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.35 Mn |
| Mar 31, 2026 | 21.58 Mn |
| Dec 31, 2025 | 23.68 Mn |
| Sep 30, 2025 | 28.52 Mn |
| Jun 30, 2025 | 31.86 Mn |
| Mar 31, 2025 | 31.92 Mn |
| Dec 31, 2024 | 27.10 Mn |
| Sep 30, 2024 | 37.85 Mn |
| Jun 30, 2024 | 49.11 Mn |
| Mar 31, 2024 | 35.69 Mn |
| Dec 31, 2023 | 47.18 Mn |
| Sep 30, 2023 | 28.81 Mn |
| Jun 30, 2023 | 34.69 Mn |
| Mar 31, 2023 | 44.33 Mn |
| Dec 31, 2022 | 52.00 Mn |
| Sep 30, 2022 | 57.94 Mn |
| Jun 30, 2022 | 44.10 Mn |
| Mar 31, 2022 | 50.94 Mn |
| Dec 31, 2021 | 57.40 Mn |
| Sep 30, 2021 | 62.85 Mn |
API Access
BioLineRx Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();